ArticleJournal for immunotherapy of cancer2022

WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma.

Rosa A van Amerongen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.